These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

976 related articles for article (PubMed ID: 16187545)

  • 21. Clinical and microbiological effects in high-risk beef calves administered intranasal or parenteral modified-live virus vaccines.
    Powledge SA; McAtee TB; Woolums AR; Robin Falkner T; Groves JT; Thoresen M; Valeris-Chacin R; Richeson JT
    J Anim Sci; 2022 Nov; 100(11):. PubMed ID: 35926833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations between health and productivity in cow-calf beef herds and persistent infection with bovine viral diarrhea virus, antibodies against bovine viral diarrhea virus, or antibodies against infectious bovine rhinotracheitis virus in calves.
    Waldner CL; Kennedy RI
    Am J Vet Res; 2008 Jul; 69(7):916-27. PubMed ID: 18593246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vaccination of calves with contaminated batches of bovine herpes virus 1 vaccines did not result in infection with bovine virus diarrhea virus].
    Antonis AF; van Oirschot JT; van Es M; Bruschke CJ
    Tijdschr Diergeneeskd; 2001 Mar; 126(6):208-11. PubMed ID: 11285641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effects against abortion and fetal infection following exposure to bovine viral diarrhea virus and bovine herpesvirus 1 during pregnancy in beef heifers that received two doses of a multivalent modified-live virus vaccine prior to breeding.
    Givens MD; Marley MS; Jones CA; Ensley DT; Galik PK; Zhang Y; Riddell KP; Joiner KS; Brodersen BW; Rodning SP
    J Am Vet Med Assoc; 2012 Aug; 241(4):484-95. PubMed ID: 22852575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of multiple immune parameters after vaccination with modified live or killed bovine viral diarrhea virus vaccines.
    Reber AJ; Tanner M; Okinaga T; Woolums AR; Williams S; Ensley DT; Hurley DJ
    Comp Immunol Microbiol Infect Dis; 2006 Jan; 29(1):61-77. PubMed ID: 16543046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
    Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
    Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of antigen-specific T-cell subset activation to bovine respiratory disease viruses by a modified-live virus vaccine.
    Platt R; Burdett W; Roth JA
    Am J Vet Res; 2006 Jul; 67(7):1179-84. PubMed ID: 16817740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus.
    Rodning SP; Marley MS; Zhang Y; Eason AB; Nunley CL; Walz PH; Riddell KP; Galik PK; Brodersen BW; Givens MD
    Theriogenology; 2010 May; 73(8):1154-63. PubMed ID: 20181385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination with a modified-live bovine viral diarrhea virus (BVDV) type 1a vaccine completely protected calves against challenge with BVDV type 1b strains.
    Xue W; Mattick D; Smith L; Umbaugh J; Trigo E
    Vaccine; 2010 Dec; 29(1):70-6. PubMed ID: 21034829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serological response of guinea pigs to oily and aqueous inactivated vaccines containing a Brazilian isolate of the Bovine Viral Diarrhea Virus (BVDV).
    Jordão RS; Ribeiro CP; Pituco EM; Okuda LH; Del Fava C; Stefano Ed; Filho MM; Mehnert DU
    Res Vet Sci; 2011 Oct; 91(2):311-5. PubMed ID: 21316721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic characterization of bovine viral diarrhea viruses isolated from persistently infected calves born to dams vaccinated against bovine viral diarrhea virus before breeding.
    Bolin SR; Lim A; Grotelueschen DM; McBeth WW; Cortese VS
    Am J Vet Res; 2009 Jan; 70(1):86-91. PubMed ID: 19119952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation.
    Ficken MD; Ellsworth MA; Tucker CM; Cortese VS
    J Am Vet Med Assoc; 2006 May; 228(10):1559-64. PubMed ID: 16677126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection.
    Kovács F; Magyar T; Rinehart C; Elbers K; Schlesinger K; Ohnesorge WC
    Vet Microbiol; 2003 Oct; 96(2):117-31. PubMed ID: 14519330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fetal protection in heifers vaccinated with a modified-live virus vaccine containing bovine viral diarrhea virus subtypes 1a and 2a and exposed during gestation to cattle persistently infected with bovine viral diarrhea virus subtype 1b.
    Leyh RD; Fulton RW; Stegner JE; Goodyear MD; Witte SB; Taylor LP; Johnson BJ; Step DL; Ridpath JF; Holland BP
    Am J Vet Res; 2011 Mar; 72(3):367-75. PubMed ID: 21355740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virus neutralising antibodies against 22 bovine viral diarrhoea virus isolates in vaccinated calves.
    Hamers C; Di Valentin E; Lecomte C; Lambot M; Joris E; Genicot B; Pastoret PP
    Vet J; 2002 Jan; 163(1):61-7. PubMed ID: 11749137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weaning management of newly received beef calves with or without continuous exposure to a persistently infected bovine viral diarrhea virus pen mate: effects on health, performance, bovine viral diarrhea virus titers, and peripheral blood leukocytes.
    Richeson JT; Kegley EB; Powell JG; Beck PA; Ley BL; Ridpath JF
    J Anim Sci; 2012 Jun; 90(6):1972-85. PubMed ID: 22648754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specificity and duration of neutralizing antibodies induced in healthy cattle after administration of a modified-live virus vaccine against bovine viral diarrhea.
    Cortese VS; Whittaker R; Ellis J; Ridpath JF; Bolin SR
    Am J Vet Res; 1998 Jul; 59(7):848-50. PubMed ID: 9659549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bovine viral diarrhoea virus (BVDV) subgenotypes in diagnostic laboratory accessions: distribution of BVDV1a, 1b, and 2a subgenotypes.
    Fulton RW; Ridpath JF; Ore S; Confer AW; Saliki JT; Burge LJ; Payton ME
    Vet Microbiol; 2005 Nov; 111(1-2):35-40. PubMed ID: 16263224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutralizing antibody responses in preconditioned calves following vaccination for respiratory viruses.
    Grooms DL; Coe P
    Vet Ther; 2002; 3(2):119-27. PubMed ID: 19750742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virus detection by PCR following vaccination of naive calves with intranasal or injectable multivalent modified-live viral vaccines.
    Walz PH; Newcomer BW; Riddell KP; Scruggs DW; Cortese VS
    J Vet Diagn Invest; 2017 Sep; 29(5):628-635. PubMed ID: 28545321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.